Cyclerion Therapeutics (CYCN) Operating Expenses (2018 - 2025)

Cyclerion Therapeutics' Operating Expenses history runs 8 years deep, the most recent figure standing at $1.9 million for Q3 2025.

• In Q3 2025, Operating Expenses rose 42.28% year-over-year to $1.9 million; the TTM figure through Dec 2025 stood at $5.2 million (down 7.89% YoY), while the FY2024 annual figure was $5.6 million, down 56.54% from the prior year.
• Operating Expenses was $1.9 million for Q3 2025 at Cyclerion Therapeutics, up from $1.8 million in the prior quarter.
• In the past five years, Operating Expenses ranged from a high of $19.2 million in Q2 2021 to a low of $1.3 million in Q4 2024.
• Historically, Operating Expenses has averaged $6.3 million across 5 years, with a median of $3.3 million in 2023.
• The sharpest annual moves came in 2023 and 2025: Operating Expenses slumped 86.43% in 2023, then surged 42.28% in 2025.
• A 5-year view of Operating Expenses shows it stood at $14.9 million in 2021, then slumped by 70.04% to $4.5 million in 2022, then plunged by 59.71% to $1.8 million in 2023, then fell by 27.35% to $1.3 million in 2024, then soared by 44.25% to $1.9 million in 2025.
• The last three Operating Expenses figures came in at $1.9 million (Q3 2025), $1.8 million (Q2 2025), and $1.5 million (Q1 2025), per Business Quant data.